Bullous pemphigoid in young individuals is an infrequent entity with less than 0.5 per million population (
3). Genetic and environmental factors can contribute to triggering bullous pemphigoid. This subepidermal blistering disorder can also be induced by certain drugs such as antihypertensives (captopril, enalapril, losartan, and beta blockers), furosemide, spironolactone, and antibiotics like ampicillin, cephalexin, and ciprofloxacin. Patients with drug-induced BP have a younger age of onset (
5,
6), but both our cases denied a history of drug intake. The pathomechanism includes autoantibodies against BP180 and BP230 antigens, which are components of the dermo-epidermal junction (
7). Anti-BP180 autoantibodies of various immunoglobulin isotypes and IgG subclasses are present in bullous pemphigoid sera, with IgG being predominant, followed by IgE. Serum levels of anti-BP180-NC16A IgG and IgE correlate well with disease activity in bullous pemphigoid (
8,
9). However, due to unavailability, indirect immunofluorescence studies were not done in our cases.
BP lesions mostly present over flexors and abdomen as tense blisters on the urticarial base, with negative Nikolsky's sign. Most patients experience prodromal symptoms of pruritus and urticarial lesions weeks or months before the eruption of blisters (
2); nevertheless, it was not present in our cases. Mucous membranes are rarely affected. However, there are certain clinical variants: Classic, localized, pemphigoid vegetans, dyshidrosiform, pigmented, nodular, papular, erythrodermic, toxic epidermal necrolysis-like, etc. (
10). The classic form of BP is characterized by large, tense blisters on normal skin or on an erythematous base with lesions most commonly on flexural surfaces, the lower abdomen, and thighs, although they may occur anywhere, as in our patients. In the second patient, vesicles and bullae were predominantly present over the face and extremities. Localized BP is an unusual variant with less than 20 cases reported in young people so far (
11), with the most common site being lower limbs or over surgical/burn/trauma scar, radiation therapy, and phototherapy site (
12), but in our case, it developed de novo over the right forearm. The bullae are typically filled with serous fluid but may be hemorrhagic with a positive bulla spread sign and negative Nikolsky's sign. Epidermolysis bullosa acquisita (EBA) was ruled out because of the patient's age and lesion site. EBA is another subepidermal immunobullous disorder, which predominantly presents in elderly males as tense bullae over the sites of friction and trauma. The investigations confirming the diagnosis of BP in our patients included biopsy from intact blister for histopathological examination and perilesional biopsy for direct immunofluorescence studies.
Histopathology findings in BP are subepidermal blisters, and inflammatory infiltrates consisting of neutrophils, eosinophils, and lymphocytes/macrophages (
13). Direct immunofluorescence shows linear IgG and C3 deposition in the basement membrane (
14), often with elevated IgE and peripheral eosinophilia (
15). However, serum IgE level was normal in both cases, and peripheral eosinophilia was not seen. The salt split technique also differentiates BP, epidermolysis bullosa acquisita, and bullous lupus erythematosus. It is performed by incubating punch biopsy specimens in 5 mL NaCl (1 mol/L) at 4°C for 24 hours, followed by separating the epidermis from the dermis using fine forceps (
16). Bullous pemphigoid (BP) demonstrates roof pattern (autoantibody deposition on the epidermal side of the cleavage as major target antigens located in the upper portion of lamina lucida), while floor pattern is observed in epidermolysis bullosa acquisita. The primary treatment modalities are topical steroids for mild disease and oral steroids along with other anti-inflammatory drugs (doxycycline, dapsone, and nicotinamide) for moderate to severe disease, in addition to supportive treatment like antihistaminics and antibiotics. Immunosuppressants, like azathioprine, mycophenolate mofetil, and methotrexate, and biologics, like rituximab and omalizumab, are usually reserved for severe or recalcitrant disease. Both patients in this study responded satisfactorily to a combination of oral prednisolone, doxycycline, and nicotinamide, along with local care. Few cases of bullous pemphigoid in young individuals have been documented in the literature. In a case series of three patients, a 43-year-old woman presented with intense itching, followed by extensive urticarial plaques and papulonodular lesions after the ingestion of captopril, while another 49-year-old female developed nasal, oral, and genital mucosal erosions with widespread vesiculobullous eruptions following the intake of losartan. All three cases had elevated serum IgE with peripheral eosinophilia and were treated successfully with a combination of dapsone and systemic corticosteroids, along with discontinuation of the culprit drugs.